Table 2.
Cell linelaboratory | Entity | Species | Seeding number | Tumor weight (mg) | Days p.i. | Reference (DOI) |
---|---|---|---|---|---|---|
A4311 | squamous cell | human | 1 x 106 | 46.1 | 7 | unpublished |
A5492 | lung | human | 3 x 106 | 33.0 | 10 | (32) |
A3753 | melanoma | human | 2 x 106 | 34.0 | 7 | (40) |
B16F10-luc1 | melanoma | murine | 1 x 106 | 36.0 | 6 | unpublished |
CT26-luc1 | colon | murine | 1 x 106 | 30.6 | 6 | (13) |
CT26-luc1 | colon | murine | 2 x 106 | 32.6 | 6 | (12) |
HT291 | colon | human | 1 x 106 | 35.2 | 6 | unpublished |
HT10804 | fibrosarcoma | human | 8 x 104 | 64.0 | 7 | (31) |
KPC960GFP-luc1 | pancreatic | murine | 1 x 106 | 25.6 | 7 | unpublished |
MC381 | colon | human | 1 x 106 | 6.60 | 7 | unpublished |
MDA-MB-2315 | breast | human | 2 x 106 | 5.10 | 9 | (21) |
MDA-MB-2316 | breast | human | 1 x 106 | 74.0 | 9 | (34) |
MiaPaca7 | pancreatic | human | 2 x 106 | 93.3 | 6 | (41) |
MiaPaca3 | pancreatic | human | 2 x 106 | 14.0 | 5 | (42) |
MiaPaca3 | pancreatic | human | 2 x 106 | 52.0 | 7 | (42) |
MiaPaca1 | pancreatic | human | 2 x 106 | 33.0 | 6 | (10) |
Panc011 | pancreatic | human | 1 x 106 | 39.3 | 6 | unpublished |
Panc011 | pancreatic | human | 2 x 106 | 27.5 | 6 | (10) |
PaTuS7 | pancreatic | human | 2 x 106 | 105 | 6 | (41) |
PaTuS1 | pancreatic | human | 2 x 106 | 24.0 | 6 | (10) |
PaTuT1 | pancreatic | human | 2 x 106 | 30.5 | 6 | (10) |
PDA66067 | pancreatic | murine | 2 x 106 | 37.5 | 3 | (43) |
PDA66067 | pancreatic | murine | 2 x 106 | 35.0 | 6 | (11) |
RB-3558 | retinoblastoma | human | 1 x 106 | 50.0 | 7 | (44) |
RT-1121 | urothelial | human | 1 x 106 | 9.72 | 7 | unpublished |
RLT-PSC3 | stellate cells | human | 2 x 106 | 8.00 | 5 | (42) |
RLT-PSC3 | stellate cells | human | 2 x 106 | 13.0 | 7 | (42) |
SCaBER1 | urothelial | human | 1 x 106 | 23.6 | 7 | unpublished |
SCC7-luc1 | squamous cell | murine | 2 x 106 | 36.0 | 6 | (12) |
SKOV31 | ovarian | human | 1 x 106 | 39.9 | 6 | unpublished |
T241 | urothelial | human | 1 x 106 | 20.0 | 7 | unpublished |
UKF-NB-49 | neuroblastoma | human | 1 x 106 | 70.0 | 7 | (45) |
WERI-Rb18 | retinoblastoma | human | 1 x 106 | 52.0 | 7 | (44) |
Y-798 | retinoblastoma | human | 1 x 106 | 62.0 | 7 | (44) |
1 ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany; 2 Cancer Target and Experimental Therapeutics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; 3 Research Group PLASMANT, Department of Chemistry, University of Antwerp, BE2610 Wilrijk-Antwerp, Belgium; 4 Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada; 5 Department of Internal Medicine II, University Hospital Ulm, Ulm, Germany; 6 Department of Physiology and Biophysics, Weill Cornell Medicine—Qatar, Doha 24144, Qatar; 7 Department of General, Visceral, Thoracic, and Vascular Surgery, Greifswald University Medical Center, 17475 Greifswald, Germany; 8 Institute of Anatomy II, Department of Neuroanatomy, University of Duisburg-Essen, Germany; 9 Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia.